Offer - Urjas Oil for just ₹ 1 X
Carca 3.125 Tablet (15) is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of High BP. The alternative uses of Carca 3.125 Tablet (15) have also been explained below.
The right dosage of Carca 3.125 Tablet (15) depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Carca 3.125 Tablet (15) as well, which are listed below. Normally, these side effects of Carca 3.125 Tablet (15) are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Carca 3.125 Tablet (15) has a Moderate effect for pregnant women and Safe effect on lactating mothers. Warnings related to Carca 3.125 Tablet (15)'s effects on the liver, heart and kidney, if any, have been listed below.
Carca 3.125 Tablet (15) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetes, Bradycardia (Slow Heart Rate), Peripheral Vascular Disease (PVD) are examples of such conditions. Other contraindications of Carca 3.125 Tablet (15) have been discussed in the sections ahead.
Drug reaction of Carca 3.125 Tablet (15) with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Carca 3.125 Tablet (15), it is important to know that it is not safe while driving, and is not habit-forming.
Carca 3.125 Tablet (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Carca 3.125 Tablet (15) safe for pregnant women?
Carca can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Carca right away. Take your doctor's advice before taking it again.
Is the use of Carca 3.125 Tablet (15) safe during breastfeeding?
Carca is completely safe for breastfeeding women.
What is the effect of Carca 3.125 Tablet (15) on the Kidneys?
There are no side effects of Carca on the kidneys.
What is the effect of Carca 3.125 Tablet (15) on the Liver?
Carca has very mild side effects on the liver.
What is the effect of Carca 3.125 Tablet (15) on the Heart?
Carca is rarely harmful for the heart.
Carca 3.125 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Carca 3.125 Tablet (15) unless your doctor advises you to do so -
Is this Carca 3.125 Tablet (15) habit forming or addictive?
Carca 3.125 Tablet (15) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Carca 3.125 Tablet (15) as you may feel sleepy.
Is it safe?
Carca 3.125 Tablet (15) should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Carca 3.125 Tablet (15) for mental disorders.
Interaction between Food and Carca 3.125 Tablet (15)
Eating certain foods may increase the time it takes Carca 3.125 Tablet (15) to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Carca 3.125 Tablet (15)
Consuming Carca 3.125 Tablet (15) with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)